Author:
Schneider N. R.,Lobaugh M.,Tan Z.,Sandwall P.,Chen P.,Glover S. E.,Cui L.,Murry M.,Dong Z.,Torgue J.,Spitz H. B.
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Spectroscopy,Pollution,Radiology Nuclear Medicine and imaging,Nuclear Energy and Engineering,Analytical Chemistry
Reference25 articles.
1. Stigbrand T, Carlsson J, Adams P (2008) Targeted radionuclide tumor therapy. Springer, Philadelphia
2. Hudis CA (2007) Trastuzumab—mechanism of action and use in clinical practice. New England J of Med 357:39–51
3. Goldenberg M (1999) Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 21:309–317
4. Goldstein A, Zong Y, Wittle O (2011) A two-step toward personalized therapies for prostate cancer. Sci Transl Med 3:1–8
5. Tan Z, Chen P, Schneider N, Glover S, Cut L, Torgue J, Rixe O, Spitz H, Dong Z (2012) Significant systemic therapeutic effects of high-LET immunoradiation by 212-Pb-trastuzumab against prostatic tumors of androgen-independent human prostate cancer in mice. Intern J Oncol 40:1881–1888
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献